These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20031652)

  • 1. High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries.
    Shinke T; Li J; Chen JP; Pendyala L; Goodchild T; Jabara R; Geva S; Ueno T; Chronos N; Robinson K; Hou D
    Circ Cardiovasc Interv; 2008 Aug; 1(1):28-35. PubMed ID: 20031652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between large angiographic late loss and low risk of in-stent thrombus: angioscopic comparison between paclitaxel- and sirolimus-eluting stents.
    Takano M; Yamamoto M; Murakami D; Inami S; Okamatsu K; Seimiya K; Ohba T; Seino Y; Mizuno K
    Circ Cardiovasc Interv; 2008 Aug; 1(1):20-7. PubMed ID: 20031651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress.
    Pendyala LK; Li J; Shinke T; Geva S; Yin X; Chen JP; King SB; Robinson KA; Chronos NA; Hou D
    JACC Cardiovasc Interv; 2009 Mar; 2(3):253-62. PubMed ID: 19463433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference of neointimal formational pattern and incidence of thrombus formation among 3 kinds of stents: an angioscopic study.
    Hara M; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Yamaguchi H; Tanouchi J; Yamada Y
    JACC Cardiovasc Interv; 2010 Feb; 3(2):215-20. PubMed ID: 20170880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
    Llano R; Winsor-Hines D; Patel DB; Seifert PS; Hamamdzic D; Wilson GJ; Wang H; Keane MG; Huibregtse BA; Wilensky RL
    Circ Cardiovasc Interv; 2011 Oct; 4(5):438-46. PubMed ID: 21972400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model.
    Farhan S; Hemetsberger R; Matiasek J; Strehblow C; Pavo N; Khorsand A; Petneházy O; Petrási Z; Kaider A; Glogar D; Huber K; Gyöngyösi M
    Atherosclerosis; 2009 Jan; 202(1):144-51. PubMed ID: 18514201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after Paclitaxel-eluting stent implantation: comparison between 6- and 18-month follow-up.
    Hara M; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Clin Cardiol; 2011 May; 34(5):322-6. PubMed ID: 21432859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima.
    Yokoyama S; Takano M; Yamamoto M; Inami S; Sakai S; Okamatsu K; Okuni S; Seimiya K; Murakami D; Ohba T; Uemura R; Seino Y; Hata N; Mizuno K
    Circ Cardiovasc Interv; 2009 Jun; 2(3):205-12. PubMed ID: 20031717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
    Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF
    EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vascular response to overlapped paclitaxel-eluting stents in swine coronary arteries.
    Seifert PS; Huibregtse BA; Polovick J; Poff B
    Cardiovasc Revasc Med; 2007; 8(4):251-8. PubMed ID: 18053947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
    Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents.
    Awata M; Nanto S; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Minamiguchi H; Kotani J; Nagata S
    JACC Cardiovasc Interv; 2009 May; 2(5):453-8. PubMed ID: 19463470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of thrombus formation at 18 months after paclitaxel-eluting stent implantation: angioscopic comparison with sirolimus-eluting stent.
    Hara M; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Yamaguchi H; Tanouchi J; Yamada Y
    Am Heart J; 2010 May; 159(5):905-10. PubMed ID: 20435203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.